Antal Zemplényi

Biographic Data

ID6776504
NAMEAntal Zemplényi
GIVEN NAMESAntal
FAMILY NAMEZemplényi
SIGNATUREZEMPLÉNYI A
AFFILIATIONSSyreon Research Institute (Hungary)
ORCID0000-0002-0177-0264
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
WORKS AS AUTHOR8
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2023
H-INDEX0

  • Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment

    Open AccessAntal Zemplényi, Konstantin Tachkov et al.ARTICLEFrontiers in Public Health2023

    Background: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA) professionals to use AI-generated evidence for decision-making from large real-world databases (e.g., based on claims data). As part of the European Commission-funded HTx H2020 (Next Generation Health Technology Assessment) …

  • Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries

    Open AccessMaria Dimitrova, Ivett Jakab et al.ARTICLEFrontiers in Public Health2022

    Patients' perspectives are important to identify preferences, estimate values and appreciate unmet medical needs in the process of research and development and subsequent assessment of new health technologies. Patient and public involvement in health technology assessment (HTA) is essential in understanding and assessing wider implications of coverage and reimbursement decisions for patients, their relatives, caregivers, and the general populatio…

  • Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries

    Open AccessKonstantin Tachkov, Antal Zemplényi et al.ARTICLEFrontiers in Public Health2022

    The aim of this paper is to identify the barriers that are specifically relevant to the use of Artificial Intelligence (AI)-based evidence in Central and Eastern European (CEE) Health Technology Assessment (HTA) systems. The study relied on two main parallel sources to identify barriers to use AI methodologies in HTA in CEE, including a scoping literature review and iterative focus group meetings with HTx team members. Most of the other selected …

  • Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries

    Open AccessMarcell Csanadi, Zoltán Kaló et al.ARTICLEHealth Policy2022

    The importance of integrated care will increase in future health systems due to aging populations and patients with chronic multimorbidity, however, such complex healthcare interventions are often developed and implemented in higher income countries. For Central and Eastern European (CEE) countries it is important to investigate which integrated care models are transferable to their setting and facilitate the implementation of relevant models by …

  • Effects of lower screening activity during the Covid-19 pandemic on breast cancer patient pathways

    Open AccessPéter Elek, Petra Fadgyas-Freyler et al.ARTICLEHealth Policy2022

    We examined the effects of the COVID-19 pandemic on the screening, diagnosis and treatment of breast cancer in Hungary based on administrative data until June 2021, covering three pandemic waves. After correcting for trend and seasonality, the number of mammography examinations decreased by 68% in 2020q2, was around its usual level in 2020q3 and was reduced by 20-35% throughout 2020q4-2021q2. The reduction was caused by a combination of supply-si…

  • Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges

    Open AccessRita Daubner-Bendes, Rita Daubner‐Bendes et al.ARTICLEFrontiers in Public Health2021

    Objectives: Methodological challenges in the evaluation of medical devices (MDs) may be different for early and late technology adopter countries, as well as the potential health technology assessment (HTA) solutions to tackle them. This study aims to provide guidance to Central and Eastern European (CEE) countries on how to address key challenges of HTA for MDs with special focus on the transferability of scientific evidence. Methods: As part of…

  • Regulatory and HTA early dialogues in medical devices

    Open AccessCarl Rudolf Blankart, Florian Dams et al.ARTICLEHealth Policy2021

    INTRODUCTION: Specific guidance and examples for health technology assessment (HTA) of medical devices are scarce in medical device development. A more intense dialogue of competent authorities, HTA agencies, and manufactures may improve evidence base on clinical and cost-effectiveness. Especially as the new Medical Device Regulation requires more clinical evidence. METHODS: We explore the perceptions of manufacturers, competent authorities, and …

  • The Selfie project

    Open AccessFenna Leijten, Melinde Boland et al.ARTICLEInternational Journal of…2017

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)